#172 | 5 Costly Mistakes Clinicians Make That Lose You Time And Money When Selecting an International Market for Your Medtech Product (And How To Avoid Them)
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
#172 | 5 Costly Mistakes Clinicians Make That Lose You Time And Money When Selecting an International Market for Your Medtech Product (And How To Avoid Them)
-
ナレーター：
-
著者：
概要
If you only had 14 months of runway left, no international sales team, and one shot at entering a new export market… would you choose the one that looks impressive or the one that actually gives you the highest probability of revenue?
Most MedTech founders believe they’re making rational expansion decisions but under pressure, choices get driven by ego, investor optics, or the allure of a “big” market. With limited runway, one wrong move can quietly burn capital and delay global traction.
In the previous episode, you built your export business plan. Today, we pressure-test it. We walk through the exact scenario I posed and reveal which market actually wins when you apply disciplined strategy instead of ambition.
In this episode, you’ll see exactly how to eliminate two markets and confidently choose the one most likely to generate traction within 12 months.
By listening, you’ll:
- See how to apply your export business plan to eliminate the wrong markets with confidence
- Learn how to balance ambition with execution probability inside a 14-month runway
- Use a 180-day reality filter to validate traction before committing capital and credibility
Press play now to learn how to choose the export market that compounds your growth not the one that drains your runway.
Message me via DM on Linkedin
Book a 30 min discovery call for the Healthcare Export Accelerator Programme
This podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.